442 related articles for article (PubMed ID: 26071559)
1. Langerhans Cells Maintain Local Tissue Tolerance in a Model of Systemic Autoimmune Disease.
King JK; Philips RL; Eriksson AU; Kim PJ; Halder RC; Lee DJ; Singh RR
J Immunol; 2015 Jul; 195(2):464-76. PubMed ID: 26071559
[TBL] [Abstract][Full Text] [Related]
2. IL-10 regulates murine lupus.
Yin Z; Bahtiyar G; Zhang N; Liu L; Zhu P; Robert ME; McNiff J; Madaio MP; Craft J
J Immunol; 2002 Aug; 169(4):2148-55. PubMed ID: 12165544
[TBL] [Abstract][Full Text] [Related]
3. Expression of natural autoantibodies in MRL-lpr mice protects from lupus nephritis and improves survival.
Mannoor K; Matejuk A; Xu Y; Beardall M; Chen C
J Immunol; 2012 Apr; 188(8):3628-38. PubMed ID: 22407922
[TBL] [Abstract][Full Text] [Related]
4. Murine models of cutaneous involvement in lupus erythematosus.
Ghoreishi M; Dutz JP
Autoimmun Rev; 2009 May; 8(6):484-7. PubMed ID: 19239927
[TBL] [Abstract][Full Text] [Related]
5. Rel B-modified dendritic cells possess tolerogenic phenotype and functions on lupus splenic lymphocytes in vitro.
Wu H; Lo Y; Chan A; Law KS; Mok MY
Immunology; 2016 Sep; 149(1):48-61. PubMed ID: 27278094
[TBL] [Abstract][Full Text] [Related]
6. Cutting edge: migration of langerhans dendritic cells is impaired in autoimmune dermatitis.
Eriksson AU; Singh RR
J Immunol; 2008 Dec; 181(11):7468-72. PubMed ID: 19017935
[TBL] [Abstract][Full Text] [Related]
7. IL-21 receptor is required for the systemic accumulation of activated B and T lymphocytes in MRL/MpJ-Fas(lpr/lpr)/J mice.
Rankin AL; Guay H; Herber D; Bertino SA; Duzanski TA; Carrier Y; Keegan S; Senices M; Stedman N; Ryan M; Bloom L; Medley Q; Collins M; Nickerson-Nutter C; Craft J; Young D; Dunussi-Joannopoulos K
J Immunol; 2012 Feb; 188(4):1656-67. PubMed ID: 22231702
[TBL] [Abstract][Full Text] [Related]
8. A new role for B cells in systemic autoimmunity: B cells promote spontaneous T cell activation in MRL-lpr/lpr mice.
Chan O; Shlomchik MJ
J Immunol; 1998 Jan; 160(1):51-9. PubMed ID: 9551955
[TBL] [Abstract][Full Text] [Related]
9. CD1d deficiency exacerbates inflammatory dermatitis in MRL-lpr/lpr mice.
Yang JQ; Chun T; Liu H; Hong S; Bui H; Van Kaer L; Wang CR; Singh RR
Eur J Immunol; 2004 Jun; 34(6):1723-32. PubMed ID: 15162443
[TBL] [Abstract][Full Text] [Related]
10. Skin disease is prevented but nephritis is accelerated by multiple pregnancies in autoimmune MRL/LPR mice.
Kökény G; Godó M; Nagy E; Kardos M; Kotsch K; Casalis P; Bodor C; Rosivall L; Volk HD; Zenclussen AC; Hamar P
Lupus; 2007; 16(7):465-77. PubMed ID: 17670844
[TBL] [Abstract][Full Text] [Related]
11. Abnormal thymic maturation and lymphoproliferation in MRL-Fas
Ashman RF; Singh N; Lenert PS
Lupus; 2017 Jun; 26(7):734-745. PubMed ID: 27837196
[TBL] [Abstract][Full Text] [Related]
12. B and T cell tolerance and autoimmunity in autoantibody transgenic mice.
Yan J; Mamula MJ
Int Immunol; 2002 Aug; 14(8):963-71. PubMed ID: 12147633
[TBL] [Abstract][Full Text] [Related]
13. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
Lichtnekert J; Rupanagudi KV; Kulkarni OP; Darisipudi MN; Allam R; Anders HJ
J Immunol; 2011 Sep; 187(6):3413-21. PubMed ID: 21849682
[TBL] [Abstract][Full Text] [Related]
14. Immunological mechanisms and clinical implications of regulatory T cell deficiency in a systemic autoimmune disorder: roles of IL-2 versus IL-15.
Yang CH; Tian L; Ling GS; Trendell-Smith NJ; Ma L; Lo CK; Stott DI; Liew FY; Huang FP
Eur J Immunol; 2008 Jun; 38(6):1664-76. PubMed ID: 18465774
[TBL] [Abstract][Full Text] [Related]
15. Knocking out of CD38 accelerates development of a lupus-like disease in lpr mice.
Viegas MS; Silva T; Monteiro MM; do Carmo A; Martins TC
Rheumatology (Oxford); 2011 Sep; 50(9):1569-77. PubMed ID: 21586522
[TBL] [Abstract][Full Text] [Related]
16. Programmed death ligand 1 regulates a critical checkpoint for autoimmune myocarditis and pneumonitis in MRL mice.
Lucas JA; Menke J; Rabacal WA; Schoen FJ; Sharpe AH; Kelley VR
J Immunol; 2008 Aug; 181(4):2513-21. PubMed ID: 18684942
[TBL] [Abstract][Full Text] [Related]
17. Characterization of cutaneous infiltrates in MRL/lpr mice monitored from onset to the full development of lupus erythematosus-like skin lesions.
Kanauchi H; Furukawa F; Imamura S
J Invest Dermatol; 1991 Apr; 96(4):478-83. PubMed ID: 1672542
[TBL] [Abstract][Full Text] [Related]
18. Cytokine gene expression in the MRL/lpr model of lupus nephritis.
Lemay S; Mao C; Singh AK
Kidney Int; 1996 Jul; 50(1):85-93. PubMed ID: 8807576
[TBL] [Abstract][Full Text] [Related]
19. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
Pérez de Lema G; Maier H; Franz TJ; Escribese M; Chilla S; Segerer S; Camarasa N; Schmid H; Banas B; Kalaydjiev S; Busch DH; Pfeffer K; Mampaso F; Schlöndorff D; Luckow B
J Am Soc Nephrol; 2005 Dec; 16(12):3592-601. PubMed ID: 16267157
[TBL] [Abstract][Full Text] [Related]
20. Decay-accelerating factor ameliorates systemic autoimmune disease in MRL/lpr mice via both complement-dependent and -independent mechanisms.
Miwa T; Maldonado MA; Zhou L; Yamada K; Gilkeson GS; Eisenberg RA; Song WC
Am J Pathol; 2007 Apr; 170(4):1258-66. PubMed ID: 17392165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
